• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Clinical Trial Registry Accuracy and Maintenance in ALS/MND Research
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition, Swallowing and Saliva
      • Activities of Daily Living and Occupational Therapy
      • Muscles, Mobility and Exercise
      • Respiratory Care
      • Speech and Communication
      • Voice Preservation
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
    • R.A.C.E. to Diagnose ALS/MND
  • Programs & Events
    • Calendar of Events
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
  • Members
    • Member Registration
    • Forgot Password

alsmnhturkiye

  • Profile
  • Topics Started
  • Replies Created
  • Engagements
  • Favorites

Forum Replies Created

Viewing 1 post (of 1 total)
  • Author
    Posts
  • April 10, 2017 at 2:35 pm in reply to: NFL and Soccer Players – ALS/MND Statistics #2664
    alsmnhturkiye
    Participant

      Thanks Rachel, any info appreciated 😉
      Alper

    • Author
      Posts
    Viewing 1 post (of 1 total)

    Primary Sidebar

    Advocacy

    • Advocacy Toolkit

    Approved Drugs

    • Nuedexta
    • Radicava/Edaravone
    • Riluzole/Tiglutik
    • Rozebalamin / Methylcobalamin
    • Tofersen/Qalsody

    Drugs in Development

    • AB Science – Masitinib
    • NurOwn
    • Clene Nanomedicine – CNM-Au8
    • ILB
    • Kadimastem – AstroRx
    • Neuronata-R / Lenzumestrocel
    • NeuroSense – PrimeC
    • NP001
    • Prilenia Therapeutics – Pridopidine
    • SOD1 Therapies & Trials
    • SPG302
    • Regulatory T Cell Enhancing Therapies
    • Ulefnersen

    Care services

    • Genetic Counselling & Testing
    • Mental Health Support
    • Nursing and Symptom Management
    • Nutrition, Swallowing and Saliva
    • Activities of Daily Living and Occupational Therapy
    • Muscles, Mobility and Exercise
    • Respiratory Care
    • Speech and Communication
    • Support for Family & Caregivers
    • Technology

    Support for members

    • Alliance Support Grant
    • About the meetings

    Programs & Events

    • Calendar of Events/Programs
    • Alliance Webinars
    • Alliance Meeting
    • Allied Professionals Forum
    • ALS/MND Connect
    • Global Day Calendar
    • March of Faces
    • International Symposium

    About

    • Who We Are
    • Board of Trustees
    • Councils, Forums & Committees
      • PALS and CALS Advisory Council
      • Scientific Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
      • Meetings
    • Awards

    Upcoming Events

    Oct 13
    8:00 am - 9:00 am EDT

    Member Forum: Technology Solutions for PALS

    Oct 13
    6:00 pm - 7:00 pm EDT

    Member Forum: Technology Solutions for PALS

    Oct 15
    9:00 am - 10:00 am EDT

    Webinar: The Use of AI in ALS/MND

    Oct 17
    2:00 pm - 3:00 pm EDT

    ALS Association Webinar: So, What’s Next? Understanding the Decisions along an ALS Journey

    Oct 21
    7:00 am - 8:30 am EDT

    Member Roundtable: Defining Rights in the Genetics Era of ALS/MND

    View Calendar

    • Maurice LeClerc, Canada

      Maurice LeClerc, Canada

    • Enzo Maccarrone, Italy

      Enzo Maccarrone, Italy

    • Marcelo Farinelli, Brazil

      Marcelo Farinelli, Brazil

    • Xian-Zhang Niu, China

      Xian-Zhang Niu, China

    • Joy Blakeley, Australia

      Joy Blakeley, Australia

    • Inta Grubb, Australia

      Inta Grubb, Australia

    • Oliver Juenke, Germany

      Oliver Juenke, Germany

    • Chun Ju Xiao, China

      Chun Ju Xiao, China

    • Claudia Gotti, Brazil

      Claudia Gotti, Brazil

    • Jan Zuring, Netherlands

      Jan Zuring, Netherlands

    • Peng Yi-Wen, Taiwan

      Peng Yi-Wen, Taiwan

    • Maurice Leclerc, Canada

      Maurice Leclerc, Canada

    • Motoko Ogasawara, Japan

      Motoko Ogasawara, Japan

    • Graham Johnson, Australia

      Graham Johnson, Australia

    • Sally Pauls, USA

      Sally Pauls, USA

    • Bob Simonds, USA

      Bob Simonds, USA

    • Frank Bos, Netherlands

      Frank Bos, Netherlands

    • Daniela Maria Daverio, Argentina

      Daniela Maria Daverio, Argentina

    • Ywan Dierick, Belgium

      Ywan Dierick, Belgium

    • Charlie Dourney, USA

      Charlie Dourney, USA

    • Lin Yong Yi, Taiwan

      Lin Yong Yi, Taiwan

    • Semra Gokalp, Turkey

      Semra Gokalp, Turkey

    • Gisli Jonasson, Iceland

      Gisli Jonasson, Iceland

    • Yannick Richard, Canada

      Yannick Richard, Canada
      yannickrichard

    • Elkin Gaviria, Colombia

      Elkin Gaviria, Colombia

    • Angelique van der Lit-van Veldhuizen, Netherlands

      Angelique van der Lit-van Veldhuizen, Netherlands

    • Oliver Juenke, Germany

      Oliver Juenke, Germany

    • Steve Lufkin, USA

      Steve Lufkin, USA
      IMG_3993

    • Manuel Arn, Switzerland

      Manuel Arn, Switzerland

    • Carlos Alberto Arango, Colombia

      Carlos Alberto Arango, Colombia

    • Bruno Leanza Mantegna, Italy

      Bruno Leanza Mantegna, Italy

    • Joyce Rusinak, USA

      Joyce Rusinak, USA

    • Claudia Cominetti, Italy

      Claudia Cominetti, Italy

    • Ian Roberts, Australia

      Ian Roberts, Australia

    • Carlos Alberto Báez Murillo, Colombia

      Carlos Alberto Báez Murillo, Colombia

    • Anna Barrow, UK

      Anna Barrow, UK

    • Chen Chun-Chin, Malaysia

      Chen Chun-Chin, Malaysia

    • Bob Spurrier, USA

      Bob Spurrier, USA

    • Jack Buzby, USA

      Jack Buzby, USA

    • Alberto Baez Murillo, Colombia

      Alberto Baez Murillo, Colombia

    • Danny Reviers, Belgium

      Danny Reviers, Belgium
      DannyReviers

    • Carlos Gomez Matallanas, Spain

      Carlos Gomez Matallanas, Spain

    • Zelina Brito, Brazil

      Zelina Brito, Brazil

    • John Russo, USA

      John Russo, USA
      final3878

    • Brian Parsons, Canada

      Brian Parsons, Canada

    • Animesh Kumar, India

      Animesh Kumar, India

    • Jette Odgaard Villemoes, Denmark

      Jette Odgaard Villemoes, Denmark

    • Mauril Bélanger, Canada

      Mauril Bélanger, Canada

    • Natalya Rybakova, Russia

      Natalya Rybakova, Russia

    • Marco Antonio Alvarez Mercado, Mexico

      Marco Antonio Alvarez Mercado, Mexico

    Learn more about the March of Faces

    Coronavirus (COVID-19) Resources

    Instructions

    First-time users, please register by clicking the register button below this log in form. You will then be able to create a user name and password. Only Alliance members are eligible to register.

    If you have already registered, please use the details provided to log in using this form.

    Drugs No Longer in Development

    • AMX0035
    • Reldesemtiv
    • Arimoclomol
    • TUDCA

    Footer

    Stay connected to the global ALS/MND community.

    Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

     
    This field is for validation purposes and should be left unchanged.
    • Email
    • Facebook
    • LinkedIn
    • Twitter
    • YouTube
    Return to top of page

    Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

    Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


    Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login